ATHENS MEDICAL SOCIETY

ATTIKON University General Hospital, ATHENS

Presentations of Athena International Conference 2015

Thursday 19-11-2015

       

08.30-08.40 Welcome and introductions

G. Dimopoulos

(view presentation)
08.40-08.55 Evidence based medicine: the pros and cons

A. Armaganidis

(view presentation)

        

9.00-10.30

How to manage and prevent the different faces of pneumonia
Chairs : A. Armaganidis – A. Komnos

09.00-09.15 Severe CAP T. Welte (view presentation)
09.15-09.30 CAMRSA pneumonia M. Niederman (view presentation)
09.30-09.45 VAP S. Blot (view presentation)
09.45-10.00 Pneumonia in immunocompomized patients E. Azoulay (view presentation)
10.00-10.15 Prevention of invasive pneumococcal disease A. Torres (view presentation)
10.15-10.30 Questions-Discussion  

     

10.30-12.00

How to optimize the treatment for ….
Chairs : J. Pneumatikos – P. Gargalianos

10.30-10.45 Klebsiella   KPC infection G. Daikos (view presentation)
10.45-11.00 Acinetobacter   spp infection J. Garnacho-Montero (view presentation)
11.00-11.15 Pseudomonas   infection J.F. Timsit (view presentation)
11.15-11.30 Clostridium difficile   infection M. Antonelli (view presentation)
11.30-11.45 Abdominal   infections J. DeWaele (view presentation)
11.45-12.00 Questions-Discussion  

 

12.00-13.30 Break  

         

13.30-15.00

How to treat in the ICU a patient with...
Chairs : A. Koutsoukou – A. Pefanis

13.30-13.45 HIV sepsis E. Azoulay (view presentation)
13.45-14.00 CMV reactivation N. Bréchot (view presentation)
14.00-14.15 Endocarditis J.A. Paiva (view presentation)
14.15-14.30 Skin and soft tissue infections M. Kollef (view presentation)
14.30-14.45 Malaria M. Singer  
14.45-15.00 Questions-Discussion  

 

15.00-16.30

How to use in the ICU……
Chairs : E. Zakynthinos –  A. Armaganidis

15.00-15.15 Adjunctive therapies E. Giamarellos  
15.15-15.30 PK/PDs D. Nicolau (view presentation)
15.30-15.45 Biomarkers J.L. Vincent  
15.45-16.00 Newer diagnostic technology for bacteria M. Kollef  
16.00-16.15 Newer diagnostic technology for fungi P. Muñoz (view presentation)
16.15-16.30 Questions - Discussion  

 

16.30-17.30 Pro/con debate
Chair : G. Dimopoulos
Targeting the microbiome! The role of SDD in the era of MDR and XDR
Pro: M. Bonden
Con: J.L. Vincent
(view presentation)

 

17.45-19.00

SATELLITE SYMPOSIUM (BAXTER)Recent trends of Esmolol in ICU
Chairs : G. Dimopoulos –  G. Baltopoulos

17.45-18.05 Esmolol as an immunomodulator agent V. Papaioannou (view presentation)
18.05-18.25 Using esmolol in daily clinical practice G. Baltopoulos (view presentation)
18.25-18.45 Heart rate control in patients with sepsis
and septic shock
Α. Κoutsoukou (view presentation)
18.45-19.00 Questions - Discussion  

 

  Opening Ceremony

 
19.30-20.00 State of the Art Lecture

 
  To Teach and To Be Taught
(When life is hanging from a thread)
C. Roussos (view presentation)

      

 

Friday 20-11-2015

 

9.00-10.30

How to fight resistance in the ICU
Chairs : G. Nakos – D. Georgopoulos

09.00-09.15 Targeting the microbial flora

M. Bonten

(view presentation)

09.15-09.30

Using antimicrobial stewardship

H. Giamarellou

(view presentation)

09.30-09.45

Using newer diagnostic technology for bacteria

A. Tsakris

(view presentation)

09.45-10.00

Using chlorhexidine bath

M. Niederman

(view presentation)

10.00-10.15

Using newer data on PK/PDs

J. De Waele

(view presentation)

10.15-10.30

Questions - Discussion

 

 

 

 10.30-12.00

How to treat fungal infections in the ICU
Chairs : S. Orfanos – G. Poulakou

10.30-10.45

Candideamia/Invasive Candidiasis

J.F. Timsit

(view presentation)

10.45-11.00

Abdominal Candidiasis

M. Bassetti

(view presentation)
11.00-11.15

Candida biofilm

J. Garnacho-Montero

(view presentation)
11.15-11.30

Aspergillosis

J.A. Paiva

(view presentation)
11.30-11.45

Mucor and other rare infections

P. Muñoz

(view presentation)

11.45-12.00

Questions - Discussion

 

 

12.00-13.30 Break  

 

 13.30-15.00

Let’s talk about inhaled antibiotics
Chairs : A. Komnos - E. Paramythiotou

13.30-13.45

Inhaled antibiotics : the story

S. Blot

(view presentation)
13.45-14.00

Why we need inhaled antibiotics ?

T. Welte

(view presentation)
14.00-14.15

Which drugs have been used for VAP ?

A. Torres

(view presentation)
14.15-14.30

Which devices are available ?

M. Antonelli

(view presentation)
14.30-14.45

Ongoing clinical studies ?

G. Dimopoulos

(view presentation)

14.45-15.00

Questions - Discussion

 

 

 

 15.00-17.15

New or under development antibiotics and antifungals
Chairs : G. Dimopoulos – A. Skoutelis

15.00-15.15 Eravacycline M. Bassetti (view presentation)
15.15-15.30 Telavancin E. Giamarellos (view presentation)
15.30-15.45 Ceftolozane / tazobactam D. Nicolau (view presentation)
15.45-16.00 Questions - Discussion  
16.00-16.15 Tedizolid N. Bréchot (view presentation)
16.15-16.30 Ceftazidime-Avibactam M. Kollef (view presentation)
16.30-16.45 Plazomicin G. Daikos (view presentation)
16.45-17.00 Azoles-Echinocandins G. Dimopoulos (view presentation)

17.00-17.15

Questions - Discussion

 

 

17.30-19.00

SATELLITE SYMPOSIUM (NORMA)The new era: inhaled antibiotics
Chairs : G. Dimopoulos

17.30-17.55 The need for inhaled antibiotics D. Nicolau (view presentation)
17.55-18.20 Inhaled Colistin: what we have learned
during the last decade?
M. Niederman (view presentation)
18.20-18.45 Combination of inhaled antibiotics M. Kollef (view presentation)
18.45-19.00 Questions - Discussion  
Copyright © 2019 ATHENA International Conference. Design by PlanTech